This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Urologic Neoplasms, Metastatic Bladder Cancer or Urinary Tract Neoplasms
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The primary objective of this study is to ascertain whether there is evidence of longer survival relative to the control arm for three comparisons: 600 mg OGX-427 Arm to control Arm; 1000 mg OGX-427 Arm to control Arm; and pooled 600 mg and 1000 mg OGX-427 Arms to control Arm.

Provided treatments

  • Drug: OGX-427 600 mg
  • Drug: OGX-427 1000 mg
  • Drug: Placebo
  • Drug: Gemcitabine
  • Drug: Cisplatin
  • Drug: Carboplatin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01454089. The sponsor of the trial is Achieve Life Sciences and it is looking for 183 volunteers for the current phase.
Official trial title:
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma